Treace Medical Concepts Inc (TMCI)
7.63
-0.29
(-3.66%)
USD |
NASDAQ |
Nov 14, 16:00
7.64
+0.01
(+0.13%)
After-Hours: 20:00
Treace Medical Concepts Research and Development Expense (Quarterly): 4.963M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.963M |
| June 30, 2024 | 5.157M |
| March 31, 2024 | 5.259M |
| December 31, 2023 | 4.152M |
| September 30, 2023 | 4.35M |
| June 30, 2023 | 3.526M |
| March 31, 2023 | 3.412M |
| December 31, 2022 | 3.749M |
| September 30, 2022 | 3.799M |
| June 30, 2022 | 2.984M |
| Date | Value |
|---|---|
| March 31, 2022 | 3.052M |
| December 31, 2021 | 3.377M |
| September 30, 2021 | 2.537M |
| June 30, 2021 | 2.422M |
| March 31, 2021 | 1.868M |
| December 31, 2020 | 1.922M |
| September 30, 2020 | 1.511M |
| June 30, 2020 | 0.982M |
| March 31, 2020 | 1.433M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.982M
Minimum
Jun 2020
5.259M
Maximum
Mar 2024
3.182M
Average
3.377M
Median
Dec 2021
Research and Development Expense (Quarterly) Benchmarks
| Stryker Corp | 377.00M |
| Perspective Therapeutics Inc | 9.275M |
| Retractable Technologies Inc | 0.1991M |
| Xtant Medical Holdings Inc | 0.636M |
| Catheter Precision Inc | 0.081M |